Orencia - (250 mg; Injectable)

Generic Name	Abatacept	Innovator	BRISTOL MYERS SQUIBB
Dosage	250 mg; Injectable	Branded US Sales	More Than $1000 mn
Probable FTF	None	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	None
Complexities	No

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
******* ******			**** ** ****	****	*** ** ******

Chronology Of Events